Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Scope of the Report:
This report focuses on the Spine Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
The worldwide market for Spine Biologics is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 2550 million US$ in 2023, from 2060 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Wright Medical Technology
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Market Segment by Applications, can be divided into
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
There are 15 Chapters to deeply display the global Spine Biologics market.
Chapter 1, to describe Spine Biologics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Spine Biologics, with sales, revenue, and price of Spine Biologics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Spine Biologics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Spine Biologics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Spine Biologics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source